Loading...
XHKG
8158
Market cap10mUSD
Jul 07, Last price  
0.28HKD
1D
0.00%
1Q
-9.68%
Jan 2017
-99.45%
IPO
-97.67%
Name

China Regenerative Medicine International Ltd

Chart & Performance

D1W1MN
XHKG:8158 chart
P/E
3.10
P/S
1.18
EPS
0.09
Div Yield, %
Shrs. gr., 5y
13.62%
Rev. gr., 5y
-16.93%
Revenues
72m
-20.48%
64,952,00019,492,00024,448,00030,0002,621,000128,0001,377,000510,0002,817,00027,751,000356,987,000755,520,00072,952,00019,365,000182,136,000282,897,00041,537,00069,487,00090,617,00072,055,000
Net income
28m
+55.05%
-374,000-3,457,00018,177,000-64,569,000-42,061,000-57,109,000-61,320,000-263,442,000-250,098,000-190,902,000-184,502,000-237,738,000-1,193,501,000-395,006,000-404,226,00051,827,0004,555,000-107,699,00017,752,00027,525,000
CFO
4m
-77.62%
-1,523,000-8,472,000-18,847,000-9,444,000-102,726,00022,251,000-90,007,000-126,033,000-218,325,000-99,117,000-460,893,000-217,755,00018,751,000-23,332,000-397,741,000-3,022,000-17,654,0006,338,00018,304,0004,096,000
Dividend
Sep 24, 20020.002 HKD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

China Regenerative Medicine International Limited operates as an investment holding entity, focusing on the development and distribution of a diverse portfolio of healthcare products and associated services. The company provides extensive health management solutions, covering health condition assessments, detoxification programs, fostering internal bodily balance, nourishing vital organs, and enhancing the immune system. Additionally, its beauty offerings encompass non-surgical medical aesthetics, essential dermatological care, anti-aging skin remedies, hair revitalization, skin firming treatments, localized body contouring, and intimate restoration services. Established in 1995, the organization was previously known as China Bio-Med Regeneration Technology Limited until its rebranding to China Regenerative Medicine International Limited in March 2015. Its headquarters are situated in Tsim Sha Tsui, Hong Kong.
IPO date
Jul 18, 2001
Employees
29
Domiciled in
HK
Incorporated in
KY

Valuation

Title
HKD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122017‑04
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT